John Rim, Samsung Biologics CEO

Sam­sung’s CD­MO arm com­mits to $324M land pur­chase for a sec­ond bio cam­pus

As in­vest­ments in­to CD­MOs are gain­ing steam from sev­er­al South Ko­re­an and Japan­ese con­glom­er­ates, Sam­sung is mak­ing a big land grab.

On Mon­day, Sam­sung Bi­o­log­ics …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.